Analysis on the network pharmacology of Yinchen-Erchen Decoction in the treatment of non-alcoholic steatohepatitis
10.3760/cma.j.cn115398-20200110-00060
- VernacularTitle:茵陈二陈汤干预非酒精性脂肪性肝炎机制的网络药理学研究
- Author:
Yi ZHAO
- From:
International Journal of Traditional Chinese Medicine
2021;43(4):376-382
- CountryChina
- Language:Chinese
-
Abstract:
Objective:By adopting network pharmacology to study the mechanism of Yinchen-Erchen Decoction in treating non-alcoholic steatohepatitis (NASH). Methods:TCMSP was used to collect the chemical constituents of Yinchen-Erchen Decoction, and the effective active ingredients were obtained. Then the target of action was speculated. GeneCards database was used to collect the related genes of NASH. The visualized network of drug-target and disease-target was established by the Cytoscape software. After the analysis of key target genes, PPI network map was established to enrich GO and KEGG pathways based on key target proteins. Results:A total of 45 active ingredients and 114 drug target proteins, 463 NASH related genes and 33 drug and disease targets were obtained from the main chemical constituents of Yinchen-Erchen Decoction. The protein interaction network found that IL6, CASP3, MYC may be the key targets of Yinchen-Erchen Decoction in the treatment of NASH. GO and KEGG enrichment analysis identified 34 and 79 signal pathways related to inflammation, cell apoptosis, diabetes, NAFLD, cancer and so on. Conclusions:Yinchen-Erchen Decoction has multi-pathway and multi-target characteristics in treating NASH. It reveals the key targets, biological processes and signal pathways involved, and provide reference and basis for the following study.
